A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer

We have isolated a prostate-specific gene (NKX3.1) in humans that is homologous to theDrosophilaNK homeobox gene family. Northern blot analyses indicate that this gene is expressed at high levels in adult prostate and at a much lower level in testis, but is expressed little or not at all in several...

Full description

Saved in:
Bibliographic Details
Published in:Genomics (San Diego, Calif.) Vol. 43; no. 1; pp. 69 - 77
Main Authors: He, Wei Wu, Sciavolino, Peter J., Wing, John, Augustus, Meena, Hudson, Peter, Meissner, P.Scott, Curtis, R.Thomas, Shell, Brenda K., Bostwick, David G., Tindall, Donald J., Gelmann, Edward P., Abate-Shen, Cory, Carter, Kenneth C.
Format: Journal Article
Language:English
Published: San Diego, CA Elsevier Inc 01-07-1997
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have isolated a prostate-specific gene (NKX3.1) in humans that is homologous to theDrosophilaNK homeobox gene family. Northern blot analyses indicate that this gene is expressed at high levels in adult prostate and at a much lower level in testis, but is expressed little or not at all in several other tissues. In an androgen-dependent prostate carcinoma line, LNCaP,NKX3.1mRNA is expressed at a basal level that was increased markedly upon androgen stimulation; theNKX3.1mRNA was undetectable in several other human tumor cell lines including two androgen-independent prostate carcinoma lines. TheNKX3.1gene maps to chromosome band 8p21, a region frequently reported to undergo a loss of heterozygosity associated with tissue dedifferentiation and loss of androgen responsiveness during the progression of prostate cancer. Based on these data we propose thatNKX3.1is a candidate gene for playing a role in the opposing processes of androgen-driven differentiation of prostatic tissue and loss of that differentiation during the progression of prostate cancer.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0888-7543
1089-8646
DOI:10.1006/geno.1997.4715